BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

2 Hydroxypropyl Beta Cyclodextrin

an excipient for steroid drugs and as a lipid chelator.

300+ PubMed studies analyzed · Evidence Score: 37.9

Research Domains

2 Hydroxypropyl Beta Cyclodextrin has been studied across 21 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Oncology, 🔬 Inflammation, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 16% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with 2 Hydroxypropyl Beta Cyclodextrin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Bacitracin
2 shared targets
Moclobemide
2 shared targets
2-Acetylaminofluorene
3 shared targets
Vortioxetine
3 shared targets
Levobunolol
2 shared targets
Flumethasone
2 shared targets
Venlafaxine
2 shared targets
Fluocinonide
2 shared targets
17-alpha-Hydroxyprogesterone
2 shared targets
Estriol
2 shared targets
Loading evidence profile...

This evidence profile for 2 Hydroxypropyl Beta Cyclodextrin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.